Barclays PLC Mannkind Corp Put Options Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 12, 2020	SELL	$0.94 - $2.21 $1,786 - $4,199	-1,900 Reduced 26.39%	5,300 $9,000
Q1 2020 May 13, 2020	SELL	$0.84 - $1.76 $588 - $1,232	-700 Reduced 8.86%	7,200 $7,000
Q4 2019 Feb 10, 2020	BUY	$1.14 - $1.49 $1,367 - $1,788	1,200 Added 17.91%	7,900 $10,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.44 $1,040 - $1,440	-1,000 Reduced 12.99%	6,700 $8,000
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $31,501 - $54,332	-28,900 Reduced 78.96%	7,700 $9,000
Q1 2019 May 15, 2019	SELL	$1.14 - $2.25 $14,819 - $29,250	-13,000 Reduced 26.21%	36,600 $72,000
Q4 2018 Feb 14, 2019	BUY	$1.02 - $2.05 $38,862 - $78,105	38,100 Added 331.3%	49,600 $53,000
Q3 2018 Nov 14, 2018	BUY	$1.01 - $2.19 $2,929 - $6,351	2,900 Added 33.72%	11,500 $21,000
Q2 2018 Aug 14, 2018	SELL	$1.59 - $2.38 $6,519 - $9,758	-4,100 Reduced 32.28%	8,600 $16,000
Q1 2018 May 15, 2018	SELL	$2.28 - $3.8 $224,078 - $373,464	-98,280 Reduced 88.56%	12,700 $29,000
Q4 2017 Feb 14, 2018	SELL	$2.28 - $6.71 $126,767 - $373,076	-55,600 Reduced 33.38%	110,980 $257,000
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $191,566 - $381,468	166,580	166,580 $361,000

248

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.